Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use venlafaxine hydrochloride extended-release capsules USP safely and effectively. See full prescribing information for venlafaxine hydrochloride extended-release capsules USP. VENLAFAXINE hydrochloride extended-release capsules USP, for oral use Initial U.S. Approval: 1997
Medication labelWhy this: Advisory · dailymed-prescription
Venlafaxine hydrochloride extended-release capsules USP are indicated for the treatment of major depressive disorder (MDD). Efficacy was established in three short-term (4, 8, and 12 weeks) and two long-term, maintenance trials. Venlafaxine hydrochloride extended-release capsules USP are indicated for the treatment of Panic Disorder (PD), with or without agoraphobia. Efficacy was established in two 12-week placebo-controlled trials.
- generic_name
- venlafaxine hydrochloride
- product_names
- Venlafaxine Hydrochloride
- ndc
- 58118-0095, 58118-0096, 58118-0097, 0093-7384, 58118-0095-8, 0093-7385, 58118-0096-8, 0093-7386, 58118-0097-8
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en